Vismodegib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 998 publications
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
Journal: Journal of cutaneous medicine and surgery
Published: March 25, 2026
Clinical Prioritization of Adverse Events Associated With Hedgehog Pathway Inhibitors in Basal Cell Carcinoma Patients: Insights From the FDA Adverse Event Reporting (FAERS) System.
Journal: Journal of cutaneous medicine and surgery
Published: March 19, 2026
Locally Advanced Basal Cell Carcinoma With Orbital Invasion: Treatment With Neoadjuvant Hedgehog Pathway Inhibition and Palliative Enucleation.
Journal: Cureus
Published: February 22, 2026
Novel green-emissive carbon dots as a dual-purpose fluorometric tool for sensitive vismodegib detection and pharmacokinetic analysis.
Journal: Analytical methods : advancing methods and applications
Published: February 17, 2026
Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 16, 2026
Synthesis and preliminary assessment of fluorescent probes based on the competitive GPCR antagonists vismodegib and masupirdine.
Journal: RSC advances
Published: February 11, 2026
Topical delivery of Vismodegib using fourth-generation PAMAM dendrimers: a potential treatment for Kaposi's sarcoma.
Journal: International journal of pharmaceutics
Published: January 07, 2026
Fractional ablative laser-enhanced transdermal delivery of vismodegib: systematic evaluation of microporation parameters and permeation kinetics.
Journal: International journal of pharmaceutics
Published: December 30, 2025
Resistance to SMO Inhibitors in Advanced Basal Cell Carcinoma: A Case Highlighting the Role of Molecular Tumor Profiling.
Journal: International journal of molecular sciences
Published: December 04, 2025
Mohs Surgery Outcomes for Basal Cell Carcinoma Treated With Neoadjuvant Sonic Hedgehog Inhibitor.
Journal: International journal of dermatology
Published: November 03, 2025
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitors.
Journal: The journal of pathology. Clinical research
Published: October 22, 2025
Low-dose oral minoxidil for the management of vismodegib-induced alopecia.
Journal: JAAD case reports
Published: October 17, 2025
Last Updated: 04/28/2026